Form 4: Amgen EVP & CFO Peter H. Griffith Reports Stock Disposal
SEC Form 4
Peter H. Griffith, EVP & CFO of Amgen Inc., reported the disposal of 640 shares of common stock on April 30, 2025, to cover tax obligations related to vested restricted stock units.
Summary
- On April 30, 2025, Peter H. Griffith, the EVP & CFO of Amgen Inc., reported a transaction involving the disposal of 640 shares of Amgen's common stock.
- The shares were disposed of at a price of $288.56 per share.
- This transaction was executed to cover tax obligations related to vested restricted stock units (RSUs).
- Following the transaction, Griffith directly owns 39,694 shares of Amgen common stock, which includes 608 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction related to tax obligations.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations arising from vested equity compensation, a common practice among executives.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of the stock disposal transaction and filing date of the Form 4. |
Keywords
Amgen, Griffith, Stock Disposal, Form 4, EVP & CFO, AMGN, Insider Trading, Dividend Equivalents, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.